Literature DB >> 15861382

Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family.

Zhao-Xia Chen1, Jeffrey R Mann, Chih-Lin Hsieh, Arthur D Riggs, Frédéric Chédin.   

Abstract

The de novo methyltransferase-like protein, DNMT3L, is required for methylation of imprinted genes in germ cells. Although enzymatically inactive, human DNMT3L was shown to act as a general stimulatory factor for de novo methylation by murine Dnmt3a. Several isoforms of DNMT3A and DNMT3B with development-stage and tissue-specific expression patterns have been described in mouse and human, thus bringing into question the identity of the physiological partner(s) for stimulation by DNMT3L. Here, we used an episome-based in vivo methyltransferase assay to systematically analyze five isoforms of human DNMT3A and DNMT3B for activity and stimulation by human DNMT3L. Our results show that human DNMT3A, DNMT3A2, DNMT3B1, and DNMT3B2 are catalytically competent, while DNMT3B3 is inactive in our assay. We also report that the activity of all four active isoforms is significantly increased upon co-expression with DNMT3L, albeit to varying extents. This is the first comprehensive description of the in vivo activities of the poorly characterized human DNMT3A and DNMT3B isoforms and of their functional interactions with DNMT3L. To further elucidate the mechanism by which DNMT3L stimulates DNA methylation, we have mapped in detail the domains that mediate interaction of human DNMT3L with human DNMT3A and DNMT3B. Our results show that the C-terminus of DNMT3L is the only region required for interaction with DNMT3A and DNMT3B and that interaction takes place through the C-terminal catalytic domain of DNMT3A and DNMT3B. The implications of these findings for the regulation of de novo methyltransferases and genomic imprinting are discussed. This article contains Supplementary Material available at http://www.mrw.interscience.wiley.com/suppmat/0730-2312/suppmat/2005/95/chen.html. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861382     DOI: 10.1002/jcb.20447

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  77 in total

1.  DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Authors:  Mrinal Y Shah; Aparna Vasanthakumar; Natalie Y Barnes; Maria E Figueroa; Anna Kamp; Christopher Hendrick; Kelly R Ostler; Elizabeth M Davis; Shang Lin; John Anastasi; Michelle M Le Beau; Ivan P Moskowitz; Ari Melnick; Peter Pytel; Lucy A Godley
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

Review 2.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

3.  Replication is required for the RecA localization response to DNA damage in Bacillus subtilis.

Authors:  Lyle A Simmons; Alan D Grossman; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

4.  Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog.

Authors:  Jing-Yu Li; Min-Tie Pu; Ryutaro Hirasawa; Bin-Zhong Li; Yan-Nv Huang; Rong Zeng; Nai-He Jing; Taiping Chen; En Li; Hiroyuki Sasaki; Guo-Liang Xu
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

5.  RNA expression microarray analysis in mouse prospermatogonia: identification of candidate epigenetic modifiers.

Authors:  Christophe Lefèvre; Jeffrey R Mann
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

Review 6.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

7.  Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L.

Authors:  Renata Z Jurkowska; Arumugam Rajavelu; Nils Anspach; Claus Urbanke; Gytis Jankevicius; Sergey Ragozin; Wolfgang Nellen; Albert Jeltsch
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

8.  Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.

Authors:  Shohreh Alizadeh Shargh; Meral Sakizli; Vahid Khalaj; Abolfazl Movafagh; Hamidreza Yazdi; Elmira Hagigatjou; Aresou Sayad; Neda Mansouri; Seyed Abdolreza Mortazavi-Tabatabaei; Hamid Reza Khorram Khorshid
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

9.  The N-terminus of histone H3 is required for de novo DNA methylation in chromatin.

Authors:  Jia-Lei Hu; Bo O Zhou; Run-Rui Zhang; Kang-Ling Zhang; Jin-Qiu Zhou; Guo-Liang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo.

Authors:  Bethany L Wienholz; Michael S Kareta; Amir H Moarefi; Catherine A Gordon; Paul A Ginno; Frédéric Chédin
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.